The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDVRG.L Regulatory News (DVRG)

  • There is currently no data for DVRG

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of AGM

20 Jul 2022 13:42

RNS Number : 1791T
Deepverge PLC
20 July 2022
 

 

20 July 2022

 

 

AIM share code: DVRG

DeepVerge PLC

 

("DeepVerge" or "Company")

 

Result of Annual General Meeting

 

Following today's Annual General Meeting ("AGM"), convened by the Notice of AGM dated 20 July 2022, DeepVerge plc is pleased to announce that all resolutions set out in the Notice of AGM were approved by shareholders.

 

The results of the poll for each resolution were as follows:

 

Resolution

For

% For

Against

% Against

Withheld

1. The Company's annual accounts for the 12 months ended 31 December 2021, together with the directors' report and auditor's report thereon, be received and adopted.

 

 

41,691,936

 

99.97%

14,144

0.03%

55,099

2. To re-appoint Jeffreys Henry LLP as auditors.

 

41,547,475

 

99.71%

120,755

0.29%

92,949

3. To determine the remuneration of the auditors.

 

41,665,475

 

 

99.97%

 

 

12,755

 

 

 

0.03%

 

 

 

82,949

 

 

4. To re-elect Gerard Brandon as a director of the Company.

41,600,104

99.79%

88,872

0.21%

72,203

5. To re-elect Fionan Murray as a director of the Company.

41,643,813

99.89%

45,163

0.11%

72,203

6. To authorise the directors to allot shares pursuant to Section 551 of the Companies Act 2006.

 

41,525,376

99.70%

123,461

0.30%

112,342

7. To authorise the directors to allot equity securities (within the meaning of section 560 of the Companies Act 2006) for cash as if section 561 of the Companies Act 2006 did not apply to such allotment.

 

31,506,032

75.63%

10,149,909

24.37%

105,238

8. To authorise the directors to allot equity securities pursuant to section 551 of the Companies Act 2006, and the terms of an investment agreement made between the Company, Riverfort Global Opportunities PCC Limited and YA II PN, Ltd dated 16 March 2022.

 

 

 

 

31,530,980

 

 

 

99.61%

 

 

 

124,961

 

 

 

0.39%

 

 

 

10,105,238

9. To authorise the directors to allot securities (within the meaning of section 560 of the Companies Act 2006) for cash pursuant to the authority conferred by Resolution 8 as if section 561 of the Companies Act 2006 did not apply to such allotment.

 

31,273,928

99.51%

152,909

0.49%

10,334,342

 

As at the date of the AGM, the number of issued ordinary shares of the Company was 219,706,378 shares, which was the total number of shares entitling the holders to attend and vote for or against all resolutions. In accordance with the Company's Articles of Association, on a poll every member has one vote for every share held. Votes withheld are not votes in law and have not been counted in the calculation of the proportion of vote "for" or "against" a resolution. Proxy appointments which gave discretion to the Chairman have been included in the "for" total.

 

Following today's AGM result, a short video will be posted on the Company's website: https://www.deepverge.com/investors

 

For further information please visit https://www.deepverge.com/or contact:

 

Enquiries:

 

DeepVerge plc

Gerard Brandon, CEO

+44 (0) 7340 055 648

SPARK Advisory Partners Limited

(Nominated Adviser)

Neil Baldwin/Andrew Emmott

+44 (0) 113 370 8974

Turner Pope Investments (TPI) Limited

(Broker)

Andy Thacker/James Pope

+44 (0) 20 3621 4120

 

 

About DeepVerge

DeepVerge is an environmental and life science group of companies that develops and applies AI and IoT technology to analytical instruments for the analysis and identification of bacteria, virus and toxins; Utilising artificial intelligent data analytics to scientifically prove the impact of skincare product claims on skin

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RAGBDGDRCXDDGDG
Date   Source Headline
27th Dec 20237:00 amRNSCancellation - DEEPVERGE PLC
20th Dec 202312:30 pmRNSUpdate; exclusivity agreement with Microsaic
13th Dec 20234:38 pmRNSUpdate
14th Sep 20237:00 amRNSNew Website, Update
7th Aug 20232:30 pmRNSDisposal;Update; Related Party Trans'n-replacement
7th Aug 20237:00 amRNSDisposal; Update
2nd Aug 20239:35 amRNSBoard Change
1st Aug 20237:00 amRNSCompany Secretary Change
12th Jul 20237:00 amRNSUpdate
5th Jul 202311:26 amRNSUpdate
26th Jun 20237:30 amRNSSuspension - Deepverge PLC
26th Jun 20237:00 amRNSSale or closure of subsidiaries; share suspension
5th Jun 20237:00 amRNSCost reductions;delay to Ann. Report;New contract
19th Apr 20231:21 pmRNSMicrosaic Creditor; Update
17th Apr 20237:00 amRNS2022 revenue update - revision
24th Mar 202310:24 amRNSChange of Auditor
6th Mar 20234:35 pmRNSPrice Monitoring Extension
6th Mar 20232:05 pmRNSSecond Price Monitoring Extn
6th Mar 20232:00 pmRNSPrice Monitoring Extension
22nd Feb 20234:40 pmRNSSecond Price Monitoring Extn
22nd Feb 20234:35 pmRNSPrice Monitoring Extension
7th Feb 20237:00 amRNSBoard Appointment
6th Feb 20235:30 pmRNSSignificant contract win and Board change
2nd Feb 20234:40 pmRNSSecond Price Monitoring Extn
2nd Feb 20234:35 pmRNSPrice Monitoring Extension
9th Jan 20237:00 amRNS2022 Revenue Update
23rd Nov 20224:10 pmRNSTR-1: Notification of major holdings
22nd Nov 20227:00 amRNSAccelerated Restructuring
16th Nov 20229:00 amRNSDirector/PDMR Shareholding
14th Nov 202212:16 pmRNSResult of Meeting
11th Nov 20224:37 pmRNSHolding(s) in Company
7th Nov 20227:00 amRNSDirectorate and Management Changes
3rd Nov 202212:32 pmRNSDirectorate Change
1st Nov 20223:56 pmRNSResult of Broker Offer; Total Voting Rights
31st Oct 20222:23 pmRNSBroker Offer to raise a max of £2.5m - replacement
31st Oct 20222:18 pmRNSExtension of Broker Offer to 430pm on 31 October
28th Oct 20221:06 pmRNSExtension of Broker Offer
27th Oct 20227:01 amRNSBroker Offer to raise a maximum of £2.5m
27th Oct 20227:00 amRNS£10m Placing, Broker Option, RPTs, Notice of GM
25th Oct 20222:05 pmRNSSecond Price Monitoring Extn
25th Oct 20222:00 pmRNSPrice Monitoring Extension
25th Oct 20227:01 amRNSUpdate - Proposed Financing,Proposed Board Changes
25th Oct 20227:00 amRNSHistorical Related Party Transactions
12th Oct 20224:41 pmRNSSecond Price Monitoring Extn
12th Oct 20224:35 pmRNSPrice Monitoring Extension
12th Oct 20227:04 amRNSResponse to Market Speculation
11th Oct 202211:05 amRNSSecond Price Monitoring Extn
11th Oct 202211:00 amRNSPrice Monitoring Extension
4th Oct 20227:00 amRNSLabskin contract
30th Sep 20224:41 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.